Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy

Cureus
11 March 2019
https://pubmed.ncbi.nlm.nih.gov/31123647/

Sjogren's Syndrome is a chronic autoimmune disorder that causes the inflammation of the lacrimal and salivary glands, resulting in dryness of the eyes and mouth. In addition, fatigue and musculoskeletal pain, often described as aching, is very common. Treatment directed toward alleviating the fatigue and pain associated with Sjogren's is currently very limited. This report describes a case of a 47-year-old female with suspected Sjogren's based on long-standing dry eyes, dry mouth, joint pain, fatigue, elevated measures of inflammation, and a positive rheumatoid factor. She failed standard therapy but improved clinically with low-dose naltrexone therapy.

Keywords: autoimmune diseases; fatigue; joint pain; low dose naltrexone; sjogren syndrome.